Edgardo Rivera

Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer

G. Hortobagyi, V. Valero, J. Mejia, 2008, Cancer.

Combined‐modality treatment for isolated recurrences of breast carcinoma

Massimo Cristofanilli, G. Hortobagyi, V. Valero, 2005, Cancer.

Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma

Roman Rouzier, Lajos Pusztai, G. Hortobagyi, 2005, Cancer.

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.

Patrick Soon-Shiong, Neil Desai, G. Hortobagyi, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma

Kristine Broglio, Thomas Buchholz, G. Hortobagyi, 2006, Cancer.

Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients

Bichlien Nguyen, D. Generali, K. Yao, 2012, Annals of Surgical Oncology.

Comparison of Ductal Lavage and Random Periareolar Fine Needle Aspiration as Tissue Acquisition Methods in Early Breast Cancer Prevention Trials

Kristine Broglio, Henry Kuerer, G. Hortobagyi, 2007, Clinical Cancer Research.